HealthyDirect · GrowthFit for a long SIP
HSBC Multi Asset Allocation Fund
HSBC Mutual FundHybrid Schemes - Multi Asset Allocation Fund2.7 years
The scheme seeks to generate long-term capital growth and generate income by investing in Equity & Equity Related instruments, Debt & Money Market Securities and Gold / Silver ETFs.
- NAV
- 14.0896
- 4 Nov 2026
- 1Y
- +5.6%
- Trailing CAGR
- AUM
- ₹3,140.77 Cr
- 30 Sept 2026
- Volatility
- Medium
- 14.2% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 3 Nov 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · Risk-adjusted return sits above the documented risk-free proxy.
Buy checklist
History depth
Fail
2.7 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
0.94% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -18.7%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Praveen Ayathan · 0.6 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 42.5% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 19%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+5.6%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+12.9%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+0.9%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +12.9%
- Calendar-day CAGR
- Excess 1Y
- +2.7%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -18.7%
- Worst peak-to-trough
- Current
- -5.7%
- Below last peak
- Current spell
- 69 days
- Days below latest peak
- Time below peak
- +85%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 16 days
- 32 recovered episodes
- Longest recovery
- 194 days
- Trough to prior peak
17 Dec 2024 – 10 Sept 2025
Trough 28 Feb 2025 · recovered in 194 days
-18.7%
29 Jan 2026 – 22 Jun 2026
Trough 23 Mar 2026 · recovered in 91 days
-11.8%
26 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-8.7%
15 Oct 2024 – 5 Dec 2024
Trough 13 Nov 2024 · recovered in 22 days
-7.4%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
35
Vs category
67
Consistency
46
Risk-adjusted
52
Drawdown
53
Mean
51
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- Risk-adjusted return sits above the documented risk-free proxy.
Portfolio
30 Sept 2026 · 85 holdings · top 10 are 42.5%.
- Top 5
- 29.7%
- Top 10
- 42.5%
- Largest holding
- 9.0%
- Effective holdings
- 32.5
HSBC Gold ETF-Growth
Unspecified
9.0%
ICICI Bank Ltd
Financial
7.9%
HDFC Bank Ltd
Financial
5.1%
Lenskart Solutions Ltd.
Consumer Discretionary
4.5%
Meesho Ltd.
Consumer Discretionary
3.3%
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
360 ONE Multi Asset Allocation Fund
360 ONE Mutual Fund
- 1Y
- +7.2%
- 3Y
- n/a
- Vol
- 11.9%
- Max DD
- -9.9%
- Sharpe
- 0.77
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
DSP Multi Asset Allocation Fund
DSP Mutual Fund
- 1Y
- +7.3%
- 3Y
- +17.7%
- Vol
- 8.9%
- Max DD
- -9.7%
- Sharpe
- 1.35
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Invesco India Multi Asset Allocation Fund
Invesco Mutual Fund
- 1Y
- +6.4%
- 3Y
- n/a
- Vol
- 9.8%
- Max DD
- -11.0%
- Sharpe
- 0.70
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Mirae Asset Multi Asset Allocation Fund
Mirae Asset Mutual Fund
- 1Y
- +6.7%
- 3Y
- n/a
- Vol
- 8.8%
- Max DD
- -9.1%
- Sharpe
- 0.78
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
WhiteOak Capital Multi Asset Allocation Fund
WhiteOak Capital Mutual Fund
- 1Y
- +6.8%
- 3Y
- +16.0%
- Vol
- 5.6%
- Max DD
- -6.1%
- Sharpe
- 1.62
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns